{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T16:34:33Z","timestamp":1783960473407,"version":"3.55.0"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T00:00:00Z","timestamp":1765584000000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Vancomycin-resistant enterococci (VRE) bacteremia is associated with substantial mortality. Rapid molecular diagnostic testing (RMDT) that detects enterococci and vancomycin resistance genes from positive blood culture broths may lead to earlier appropriate antimicrobial therapy for VRE bacteremia, which could improve clinical outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective cohort study of patients with VRE bacteremia from 2010 to 2019. RMDT that detects enterococci and vancomycin resistance genes from positive blood cultures was implemented in October 2014. We compared time to active antimicrobial administration, mortality, and other outcomes in patients whose positive blood cultures underwent RMDT (postintervention) and those whose did not (preintervention).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 577 eligible patients with VRE bacteremia, 237 (41.1%) had blood cultures that underwent RMDT. The RMDT cohort had shorter median time from culture collection until receipt of active antimicrobial therapy (21 vs 32\u2005hours, P &amp;lt; .001) than the non-RMDT cohort. There was no difference in 30-day mortality (31.6% vs 36.5%, P = .230). A post hoc subgroup analysis excluding patients with leukemia (who received empiric VRE-active therapy based on Gram stain results) found that RMDT was associated with decreased 30-day mortality: 29.6% versus 40.8%, P = .037. On multivariate analysis, that improvement in 30-day mortality in patients without leukemia did not persist.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>RMDT was associated with decreased time to receipt of active antimicrobial therapy in VRE bacteremia. There was no improvement in mortality associated with the use of RMDT. RMDT for VRE bacteremia may improve time to identification and treatment of VRE bacteremia but does not clearly improve clinical outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ofid\/ofaf757","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T13:09:02Z","timestamp":1765458542000},"source":"Crossref","is-referenced-by-count":2,"title":["Impact of Rapid Molecular Diagnostic Testing on Outcomes of Patients With Vancomycin-Resistant Enterococcal Bacteremia"],"prefix":"10.1093","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2494-7867","authenticated-orcid":false,"given":"Michael R","family":"Hovan","sequence":"first","affiliation":[{"name":"Department of Medicine, Division of Pulmonary & Critical Care Medicine, NewYork-Presbyterian\/Weill Cornell Medicine , New York, New York ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J","family":"Burkitt","sequence":"additional","affiliation":[{"name":"Pittsburgh Infectious Diseases, LTD. , Pittsburgh, Pennsylvania ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sierra A","family":"Derti","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Internal Medicine, Allegheny Health Network , Pittsburgh, Pennsylvania ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith U","family":"Hargrave","sequence":"additional","affiliation":[{"name":"Clinical Microbiology Service, NewYork-Presbyterian\/Weill Cornell Medical Center , New York, New York ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela S","family":"De Cordova","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, NewYork-Presbyterian\/Weill Cornell Medical Center , New York, New York ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew S","family":"Simon","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Infectious Diseases, Weill Cornell Medicine , New York, New York ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen G","family":"Jenkins","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Infectious Diseases, Weill Cornell Medicine , New York, New York ,","place":["USA"]},{"name":"Department of Pathology and Laboratory Medicine, Weill Cornell Medicine , New York, New York ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars F","family":"Westblade","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Infectious Diseases, Weill Cornell Medicine , New York, New York ,","place":["USA"]},{"name":"Department of Pathology and Laboratory Medicine, Weill Cornell Medicine , New York, New York ,","place":["USA"]},{"name":"Department of Pediatrics, Weill Cornell Medicine , New York, New York ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4711-5334","authenticated-orcid":false,"given":"Michael J","family":"Satlin","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Infectious Diseases, Weill Cornell Medicine , New York, New York ,","place":["USA"]},{"name":"Department of Pathology and Laboratory Medicine, Weill Cornell Medicine , New York, New York ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,12,12]]},"reference":[{"key":"2026010608270042900_ofaf757-B1","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1080\/22221751.2020.1769500","article-title":"The ongoing challenge of vancomycin-resistant Enterococcus faecium and Enterococcus faecalis in Europe: an epidemiological analysis of bloodstream infections","volume":"9","author":"Ayobami","year":"2020","journal-title":"Emerg Microbes Infect"},{"key":"2026010608270042900_ofaf757-B2","author":"Centers for Disease Control"},{"key":"2026010608270042900_ofaf757-B3","author":"Centers for Disease Control"},{"key":"2026010608270042900_ofaf757-B4","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1086\/502271","article-title":"Outcomes associated with vancomycin-resistant enterococci: a meta-analysis","volume":"24","author":"Salgado","year":"2003","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2026010608270042900_ofaf757-B5","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jinf.2009.01.013","article-title":"Vancomycin-resistant enterococci bacteremia: risk factors for mortality and influence of antimicrobial therapy on clinical outcome","volume":"58","author":"Han","year":"2009","journal-title":"J Infect"},{"key":"2026010608270042900_ofaf757-B6","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.jmii.2017.08.025","article-title":"Clinical characteristics and treatment outcomes of vancomycin-resistant Enterococcus faecium bacteremia","volume":"51","author":"Ye","year":"2018","journal-title":"J Microbiol Immunol Infect"},{"key":"2026010608270042900_ofaf757-B7","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1017\/ice.2015.228","article-title":"VRE and VSE bacteremia outcomes in the era of effective VRE therapy: a systematic review and meta-analysis","volume":"37","author":"Prematunge","year":"2016","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2026010608270042900_ofaf757-B8","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.ajic.2018.05.003","article-title":"Patient- and hospital-level predictors of vancomycin-resistant Enterococcus (VRE) bacteremia in Ontario, Canada","volume":"46","author":"Johnstone","year":"2018","journal-title":"Am J Infect Control"},{"key":"2026010608270042900_ofaf757-B9","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1086\/339211","article-title":"Clinical outcomes for patients with bacteremia caused by vancomycin-resistant enterococcus in a level 1 trauma center","volume":"34","author":"Lodise","year":"2002","journal-title":"Clin Infect Dis"},{"key":"2026010608270042900_ofaf757-B10","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.idh.2019.08.006","article-title":"Bloodstream infections in neutropenic patients with haematological malignancies","volume":"25","author":"Carvalho","year":"2020","journal-title":"Infect Dis Health"},{"key":"2026010608270042900_ofaf757-B11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.12688\/f1000research.11831.1","article-title":"Vancomycin-resistant enterococcus infection in the hematopoietic stem cell transplant recipient: an overview of epidemiology, management, and prevention","volume":"7","author":"Benamu","year":"2018","journal-title":"F1000Res"},{"key":"2026010608270042900_ofaf757-B12","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1086\/342904","article-title":"Risk factors for development of vancomycin-resistant enterococcal bloodstream infection in patients with cancer who are colonized with vancomycin-resistant enterococci","volume":"35","author":"Zaas","year":"2002","journal-title":"Clin Infect Dis"},{"key":"2026010608270042900_ofaf757-B13","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.3109\/10428194.2014.896007","article-title":"The emergence of vancomycin-resistant enterococcal bacteremia in hematopoietic stem cell transplant recipients","volume":"55","author":"Satlin","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"2026010608270042900_ofaf757-B14","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1093\/cid\/ciw110","article-title":"Time is of the essence: the impact of delayed antibiotic therapy on patient outcomes in hospital-onset enterococcal bloodstream infections","volume":"62","author":"Zasowski","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2026010608270042900_ofaf757-B15","doi-asserted-by":"crossref","first-page":"11925","DOI":"10.3390\/ijms231911925","article-title":"Time to effective therapy is an important determinant of survival in bloodstream infections caused by vancomycin-resistant Enterococcus spp","volume":"23","author":"Russo","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2026010608270042900_ofaf757-B16","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1186\/s12879-022-07772-x","article-title":"Performance of BioFire blood culture identification 2 panel (BCID2) for the detection of bloodstream pathogens and their associated resistance markers: a systematic review and meta-analysis of diagnostic test accuracy studies","volume":"22","author":"Peri","year":"2022","journal-title":"BMC Infect Dis"},{"key":"2026010608270042900_ofaf757-B17","doi-asserted-by":"crossref","first-page":"e100122200121","DOI":"10.2174\/1871526522666220110155719","article-title":"Efficacy of VERIGENE\u00ae blood culture assays in accurately and rapidly detecting gram-negative and gram-positive pathogens","volume":"22","author":"Guevara","year":"2022","journal-title":"Infect Disord Drug Targets"},{"key":"2026010608270042900_ofaf757-B18","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1080\/23744235.2016.1185533","article-title":"Impact of a rapid multiplex polymerase chain reaction blood culture identification technology on outcomes in patients with vancomycin-resistant Enterococcal bacteremia","volume":"48","author":"MacVane","year":"2016","journal-title":"Infect Dis (Lond)"},{"key":"2026010608270042900_ofaf757-B19","doi-asserted-by":"crossref","first-page":"4008","DOI":"10.1128\/JCM.01951-13","article-title":"Stewardship approach for optimizing antimicrobial therapy through use of a rapid microarray assay on blood cultures positive for Enterococcus species","volume":"51","author":"Sango","year":"2013","journal-title":"J Clin Microbiol"},{"key":"2026010608270042900_ofaf757-B20","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jhin.2017.12.012","article-title":"Optimization of antimicrobial therapy in vancomycin-resistant Enterococcal bacteraemia using a rapid detection gram-positive blood culture assay","volume":"99","author":"Nakagawa","year":"2018","journal-title":"J Hosp Infect"},{"key":"2026010608270042900_ofaf757-B21","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3390\/antibiotics12020210","article-title":"Molecular rapid diagnostics improve time to effective therapy and survival in patients with vancomycin-resistant enterococcus bloodstream infections","volume":"12","author":"Bandy","year":"2023","journal-title":"Antibiotics (Basel)"},{"key":"2026010608270042900_ofaf757-B22","author":"Clinical & Laboratory Standards Institute"},{"key":"2026010608270042900_ofaf757-B23","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"2026010608270042900_ofaf757-B24","doi-asserted-by":"crossref","first-page":"26","DOI":"10.7326\/0003-4819-140-1-200401060-00008","article-title":"International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum beta-lactamase production in nosocomial infections","volume":"140","author":"Paterson","year":"2004","journal-title":"Ann Intern Med"},{"key":"2026010608270042900_ofaf757-B25","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1097\/01.CCM.0000217961.75225.E9","article-title":"Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock","volume":"34","author":"Kumar","year":"2006","journal-title":"Crit Care Med"},{"key":"2026010608270042900_ofaf757-B26","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1097\/01.CCM.0000098031.24329.10","article-title":"Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis","volume":"31","author":"Garnacho-Montero","year":"2003","journal-title":"Crit Care Med"},{"key":"2026010608270042900_ofaf757-B27","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1093\/cid\/ciae234","article-title":"Rapid diagnostic tests and antimicrobial stewardship programs for the management of bloodstream infection: what is their relative contribution to improving clinical outcomes? A systematic review and network meta-analysis","volume":"79","author":"Peri","year":"2024","journal-title":"Clin Infect Dis"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofaf757\/65875027\/ofaf757.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/13\/1\/ofaf757\/65875027\/ofaf757.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/13\/1\/ofaf757\/65875027\/ofaf757.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T13:27:10Z","timestamp":1767706030000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofaf757\/8379250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,12]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12,26]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofaf757","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1]]},"published":{"date-parts":[[2025,12,12]]},"article-number":"ofaf757"}}